Breaking News — A groundbreaking study reveals that serotonin, the brain chemical boosted by many antidepressants, may actually amplify tinnitus, not soothe it. Using advanced light-based stimulation in mice, researchers pinpointed a specific neural circuit driving this effect.
"Our findings suggest that serotonin can actively worsen tinnitus symptoms, which may explain why some patients report increased ringing when taking SSRIs," said Dr. Elena Marchetti, lead neuroscientist at the University of Zurich.
Background
Tinnitus affects roughly 10–15% of adults worldwide, causing persistent phantom sounds like ringing or buzzing. While antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), are sometimes prescribed for relief, clinical reports have noted paradoxical worsening in some individuals.
Serotonin is widely known as the brain's "feel-good" chemical, regulating mood, sleep, and appetite. However, its role in auditory processing has remained unclear until now.
How the Study Worked
Researchers at the University of Zurich and Cambridge Neuroscience Institute used optogenetics — a technique that activates neurons with light — to stimulate serotonin-producing cells in the brains of mice. They then measured the animals' startle responses to silence, a standard behavioral test for tinnitus-like perception.
Mice with activated serotonin circuits showed significantly stronger startle reactions, indicating they perceived phantom sounds. The effect was specific to a pathway linking the dorsal raphe nucleus to the auditory cortex.
What This Means
This discovery challenges the conventional view that serotonin is universally therapeutic. For tinnitus patients, boosting serotonin via SSRIs could inadvertently turn up the volume on their ringing.
"Clinicians may need to reconsider prescribing SSRIs for tinnitus without first assessing individual neurotransmitter dynamics," warned Dr. Marchetti. "We hope this leads to more targeted treatments that avoid activating this harmful circuit."
Implications for Patients
- Current SSRI users with tinnitus should consult their doctor before making any changes.
- New drug designs could avoid serotonin pathways that exacerbate auditory processing.
- Behavioral therapies remain the gold standard for managing tinnitus while research advances.
Next Steps
The team is now testing whether blocking specific serotonin receptors can quiet tinnitus without affecting mood regulation. Human trials are expected within two years.
Read more about how tinnitus affects the brain or what patients should know.